A molecular biophysical approach to diclofenac topical gastrointestinal damage

Detalhes bibliográficos
Autor(a) principal: Fernandes, Eduarda
Data de Publicação: 2018
Outros Autores: Soares, Telma, Gonçalves, Hugo, Bernstorff, Sigrid, Oliveira, Maria Real, Lopes, Carla Martins, Lúcio, Marlene
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10284/8997
Resumo: Diclofenac (DCF), the most widely consumed non-steroidal anti-inflammatory drug (NSAID) worldwide, is associated with adverse typical effects, including gastrointestinal (GI) complications. The present study aims to better understand the topical toxicity induced by DCF using membrane models that mimic the physiological, biophysical, and chemical environments of GI mucosa segments. For this purpose, phospholipidic model systems that mimic the GI protective lining and lipid models of the inner mitochondrial membrane were used together with a wide set of techniques: derivative spectrophotometry to evaluate drug distribution at the membrane; steady-state and time-resolved fluorescence to predict drug location at the membrane; fluorescence anisotropy, differential scanning calorimetry (DSC), dynamic light scattering (DLS), and calcein leakage studies to evaluate the drug-induced disturbance on membrane microviscosity and permeability; and small- and wide-angle X-ray scattering studies (SAXS and WAXS, respectively), to evaluate the effects of DCF at the membrane structure. Results demonstrated that DCF interacts chemically with the phospholipids of the GI protective barrier in a pH-dependent manner and confirmed the DCF location at the lipid headgroup region, as well as DCF’s higher distribution at mitochondrial membrane contact points where the impairment of biophysical properties is consistent with the uncoupling effects reported for this drug.
id RCAP_ba122602e4f7dd9029b2779fc5af5c56
oai_identifier_str oai:bdigital.ufp.pt:10284/8997
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling A molecular biophysical approach to diclofenac topical gastrointestinal damageDiclofenacNSAIDsDerivative spectrophotometrySteady-state and time-resolved fluorescenceSteady-state anisotropyDLSDSCSAXSWAXSGastrointestinal topical toxicityDiclofenac (DCF), the most widely consumed non-steroidal anti-inflammatory drug (NSAID) worldwide, is associated with adverse typical effects, including gastrointestinal (GI) complications. The present study aims to better understand the topical toxicity induced by DCF using membrane models that mimic the physiological, biophysical, and chemical environments of GI mucosa segments. For this purpose, phospholipidic model systems that mimic the GI protective lining and lipid models of the inner mitochondrial membrane were used together with a wide set of techniques: derivative spectrophotometry to evaluate drug distribution at the membrane; steady-state and time-resolved fluorescence to predict drug location at the membrane; fluorescence anisotropy, differential scanning calorimetry (DSC), dynamic light scattering (DLS), and calcein leakage studies to evaluate the drug-induced disturbance on membrane microviscosity and permeability; and small- and wide-angle X-ray scattering studies (SAXS and WAXS, respectively), to evaluate the effects of DCF at the membrane structure. Results demonstrated that DCF interacts chemically with the phospholipids of the GI protective barrier in a pH-dependent manner and confirmed the DCF location at the lipid headgroup region, as well as DCF’s higher distribution at mitochondrial membrane contact points where the impairment of biophysical properties is consistent with the uncoupling effects reported for this drug.Repositório Institucional da Universidade Fernando PessoaFernandes, EduardaSoares, TelmaGonçalves, HugoBernstorff, SigridOliveira, Maria RealLopes, Carla MartinsLúcio, Marlene2020-09-22T14:01:28Z2020-07-23T09:46:08Z2018-10-31T00:00:00Z2018-10-31T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10284/8997eng1422-0067cv-prod-33746710.3390/ijms19113411info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-06T02:08:17Zoai:bdigital.ufp.pt:10284/8997Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:45:46.261607Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv A molecular biophysical approach to diclofenac topical gastrointestinal damage
title A molecular biophysical approach to diclofenac topical gastrointestinal damage
spellingShingle A molecular biophysical approach to diclofenac topical gastrointestinal damage
Fernandes, Eduarda
Diclofenac
NSAIDs
Derivative spectrophotometry
Steady-state and time-resolved fluorescence
Steady-state anisotropy
DLS
DSC
SAXS
WAXS
Gastrointestinal topical toxicity
title_short A molecular biophysical approach to diclofenac topical gastrointestinal damage
title_full A molecular biophysical approach to diclofenac topical gastrointestinal damage
title_fullStr A molecular biophysical approach to diclofenac topical gastrointestinal damage
title_full_unstemmed A molecular biophysical approach to diclofenac topical gastrointestinal damage
title_sort A molecular biophysical approach to diclofenac topical gastrointestinal damage
author Fernandes, Eduarda
author_facet Fernandes, Eduarda
Soares, Telma
Gonçalves, Hugo
Bernstorff, Sigrid
Oliveira, Maria Real
Lopes, Carla Martins
Lúcio, Marlene
author_role author
author2 Soares, Telma
Gonçalves, Hugo
Bernstorff, Sigrid
Oliveira, Maria Real
Lopes, Carla Martins
Lúcio, Marlene
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Institucional da Universidade Fernando Pessoa
dc.contributor.author.fl_str_mv Fernandes, Eduarda
Soares, Telma
Gonçalves, Hugo
Bernstorff, Sigrid
Oliveira, Maria Real
Lopes, Carla Martins
Lúcio, Marlene
dc.subject.por.fl_str_mv Diclofenac
NSAIDs
Derivative spectrophotometry
Steady-state and time-resolved fluorescence
Steady-state anisotropy
DLS
DSC
SAXS
WAXS
Gastrointestinal topical toxicity
topic Diclofenac
NSAIDs
Derivative spectrophotometry
Steady-state and time-resolved fluorescence
Steady-state anisotropy
DLS
DSC
SAXS
WAXS
Gastrointestinal topical toxicity
description Diclofenac (DCF), the most widely consumed non-steroidal anti-inflammatory drug (NSAID) worldwide, is associated with adverse typical effects, including gastrointestinal (GI) complications. The present study aims to better understand the topical toxicity induced by DCF using membrane models that mimic the physiological, biophysical, and chemical environments of GI mucosa segments. For this purpose, phospholipidic model systems that mimic the GI protective lining and lipid models of the inner mitochondrial membrane were used together with a wide set of techniques: derivative spectrophotometry to evaluate drug distribution at the membrane; steady-state and time-resolved fluorescence to predict drug location at the membrane; fluorescence anisotropy, differential scanning calorimetry (DSC), dynamic light scattering (DLS), and calcein leakage studies to evaluate the drug-induced disturbance on membrane microviscosity and permeability; and small- and wide-angle X-ray scattering studies (SAXS and WAXS, respectively), to evaluate the effects of DCF at the membrane structure. Results demonstrated that DCF interacts chemically with the phospholipids of the GI protective barrier in a pH-dependent manner and confirmed the DCF location at the lipid headgroup region, as well as DCF’s higher distribution at mitochondrial membrane contact points where the impairment of biophysical properties is consistent with the uncoupling effects reported for this drug.
publishDate 2018
dc.date.none.fl_str_mv 2018-10-31T00:00:00Z
2018-10-31T00:00:00Z
2020-09-22T14:01:28Z
2020-07-23T09:46:08Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10284/8997
url http://hdl.handle.net/10284/8997
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1422-0067
cv-prod-337467
10.3390/ijms19113411
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130324097040384